377 related articles for article (PubMed ID: 9565824)
41. Hyperhomocysteinaemia and end stage renal disease.
Gupta A; Robinson K
J Nephrol; 1997; 10(2):77-84. PubMed ID: 9238614
[TBL] [Abstract][Full Text] [Related]
42. Water soluble vitamins in patients with chronic renal failure and effect of B6 administration of immunological activity.
Kamata K; Okubo M; Marumo F
Proc Clin Dial Transplant Forum; 1979; 9():194-6. PubMed ID: 552042
[TBL] [Abstract][Full Text] [Related]
43. [Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy].
Ueland PM; Refsum H
Nord Med; 1989; 104(11):293-8. PubMed ID: 2813054
[TBL] [Abstract][Full Text] [Related]
44. Vitamin requirements for the treatment of hyperhomocysteinemia in humans.
Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ; Delport R; Potgieter HC
J Nutr; 1994 Oct; 124(10):1927-33. PubMed ID: 7931701
[TBL] [Abstract][Full Text] [Related]
45. Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans.
Lui A; Lumeng L; Aronoff GR; Li TK
J Lab Clin Med; 1985 Nov; 106(5):491-7. PubMed ID: 4056565
[TBL] [Abstract][Full Text] [Related]
46. High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients.
Gupta A; Moustapha A; Jacobsen DW; Goormastic M; Tuzcu EM; Hobbs R; Young J; James K; McCarthy P; van Lente F; Green R; Robinson K
Transplantation; 1998 Feb; 65(4):544-50. PubMed ID: 9500631
[TBL] [Abstract][Full Text] [Related]
47. Early effect of a low dose (30 micrograms) ethinyl estradiol-containing Triphasil on vitamin B6 status. A follow-up study on six menstrual cycles.
Massé PG; van den Berg H; Duguay C; Beaulieu G; Simard JM
Int J Vitam Nutr Res; 1996; 66(1):46-54. PubMed ID: 8698546
[TBL] [Abstract][Full Text] [Related]
48. [Socio-demographic, lifestyle, gynecological, and obstetric predictors of serum or plasma concentrations of homocysteine, folic acid, and vitamins B12 and B6 among low-income women in São Paulo, Brazil].
Almeida LC; Tomita LY; D'Almeida V; Cardoso MA
Cad Saude Publica; 2008 Mar; 24(3):587-96. PubMed ID: 18327446
[TBL] [Abstract][Full Text] [Related]
49. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.
van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA
J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188
[TBL] [Abstract][Full Text] [Related]
50. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial.
Bostom AG; Gohh RY; Beaulieu AJ; Nadeau MR; Hume AL; Jacques PF; Selhub J; Rosenberg IH
Ann Intern Med; 1997 Dec; 127(12):1089-92. PubMed ID: 9412311
[TBL] [Abstract][Full Text] [Related]
51. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.
Selhub J; Jacques PF; Bostom AG; D'Agostino RB; Wilson PW; Belanger AJ; O'Leary DH; Wolf PA; Schaefer EJ; Rosenberg IH
N Engl J Med; 1995 Feb; 332(5):286-91. PubMed ID: 7816063
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of a complex multivitamin supplement.
Earnest C; Cooper KH; Marks A; Mitchell TL
Nutrition; 2002 Sep; 18(9):738-42. PubMed ID: 12297209
[TBL] [Abstract][Full Text] [Related]
53. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
Wuillemin WA; Solenthaler M
Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
[TBL] [Abstract][Full Text] [Related]
54. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12.
Lobo A; Naso A; Arheart K; Kruger WD; Abou-Ghazala T; Alsous F; Nahlawi M; Gupta A; Moustapha A; van Lente F; Jacobsen DW; Robinson K
Am J Cardiol; 1999 Mar; 83(6):821-5. PubMed ID: 10190392
[TBL] [Abstract][Full Text] [Related]
55. The effect of pyridoxine supplementation on plasma pyridoxal-5'-phosphate levels in children with the nephrotic syndrome.
van Buuren AJ; Louw ME; Shephard GS; Labadarios D
Clin Nephrol; 1987 Aug; 28(2):81-6. PubMed ID: 3652542
[TBL] [Abstract][Full Text] [Related]
56. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
[TBL] [Abstract][Full Text] [Related]
57. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over.
Bates CJ; Pentieva KD; Prentice A; Mansoor MA; Finch S
Br J Nutr; 1999 Mar; 81(3):191-201. PubMed ID: 10434845
[TBL] [Abstract][Full Text] [Related]
58. Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients.
van der Dijs FP; Schnog JJ; Brouwer DA; Velvis HJ; van den Berg GA; Bakker AJ; Duits AJ; Muskiet FD; Muskiet FA
Am J Hematol; 1998 Nov; 59(3):192-8. PubMed ID: 9798656
[TBL] [Abstract][Full Text] [Related]
59. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
Boers GH
Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
[TBL] [Abstract][Full Text] [Related]
60. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.
Robinson K; Gupta A; Dennis V; Arheart K; Chaudhary D; Green R; Vigo P; Mayer EL; Selhub J; Kutner M; Jacobsen DW
Circulation; 1996 Dec; 94(11):2743-8. PubMed ID: 8941098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
